Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.44
+0.16 (3.03%)
Nov 21, 2024, 4:00 PM EST - Market closed
Orchestra BioMed Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 25.61 | 30.56 | 19.78 | 9.94 | 20.34 |
Short-Term Investments | 41.32 | 57.04 | 64 | 0.96 | 15.45 |
Cash & Short-Term Investments | 66.93 | 87.6 | 83.79 | 10.9 | 35.79 |
Cash Growth | -38.52% | 4.55% | 668.95% | -69.56% | - |
Receivables | 0.12 | 0.1 | 0.1 | 0.12 | 0.17 |
Inventory | 0.23 | 0.15 | 0.28 | 0.07 | 0.07 |
Prepaid Expenses | 1.28 | 1.27 | 0.53 | 0.23 | 0.23 |
Total Current Assets | 68.55 | 89.11 | 84.69 | 11.32 | 36.25 |
Property, Plant & Equipment | 2.97 | 2.83 | 3.68 | 1.12 | 1.03 |
Long-Term Investments | 2.5 | 2.5 | 2.5 | 0.4 | 0.19 |
Long-Term Deferred Charges | - | - | 4 | 0.1 | - |
Other Long-Term Assets | 1.3 | 0.77 | 0.71 | 0.59 | 0.63 |
Total Assets | 75.32 | 95.21 | 95.57 | 13.53 | 38.09 |
Accounts Payable | 4.72 | 2.9 | 3.97 | 2.03 | 1.77 |
Accrued Expenses | 7.03 | 5.15 | 5.38 | 1.89 | 1.41 |
Current Portion of Long-Term Debt | - | - | - | 2 | 4 |
Current Portion of Leases | 0.4 | 0.65 | 0.7 | - | - |
Current Unearned Revenue | 4.07 | 2.51 | 6.44 | 5.54 | 5.8 |
Other Current Liabilities | - | - | 2.09 | 0.78 | 1.38 |
Total Current Liabilities | 16.22 | 11.21 | 18.57 | 12.24 | 14.36 |
Long-Term Debt | - | - | 9.49 | 3.67 | 5.46 |
Long-Term Leases | 1.44 | 1.04 | 1.68 | - | - |
Long-Term Unearned Revenue | 11.44 | 14.92 | 13.1 | 16.86 | 15.12 |
Other Long-Term Liabilities | - | - | 0.2 | 0.54 | 0.24 |
Total Liabilities | 29.1 | 27.17 | 43.04 | 33.31 | 35.18 |
Common Stock | 0 | 0 | 0 | - | - |
Additional Paid-In Capital | 339.84 | 316.9 | 252.27 | 94.89 | 94.57 |
Retained Earnings | -293.72 | -248.85 | -199.73 | -166.13 | -143.11 |
Comprehensive Income & Other | 0.1 | -0.01 | -0.01 | - | -0 |
Total Common Equity | 46.22 | 68.04 | 52.53 | -71.23 | -48.54 |
Shareholders' Equity | 46.22 | 68.04 | 52.53 | -19.78 | 2.91 |
Total Liabilities & Equity | 75.32 | 95.21 | 95.57 | 13.53 | 38.09 |
Total Debt | 1.84 | 1.69 | 11.87 | 5.67 | 9.46 |
Net Cash (Debt) | 65.09 | 85.91 | 71.92 | 5.22 | 26.33 |
Net Cash Growth | -33.17% | 19.46% | 1276.89% | -80.17% | - |
Net Cash Per Share | 1.80 | 2.59 | 4.80 | 2.47 | 13.08 |
Filing Date Shares Outstanding | 38.01 | 35.78 | 2.52 | 2.19 | 2.01 |
Total Common Shares Outstanding | 37.94 | 35.78 | 2.52 | 2.19 | 2.01 |
Working Capital | 52.34 | 77.91 | 66.12 | -0.92 | 21.89 |
Book Value Per Share | 1.22 | 1.90 | 20.83 | -32.60 | -24.11 |
Tangible Book Value | 46.22 | 68.04 | 52.53 | -71.23 | -48.54 |
Tangible Book Value Per Share | 1.22 | 1.90 | 20.83 | -32.60 | -24.11 |
Machinery | 2.32 | 2.12 | 2.08 | 1.51 | 1.24 |
Construction In Progress | - | - | - | 0.02 | 0.04 |
Leasehold Improvements | 0.16 | 0.2 | 0.19 | 0.18 | 0.17 |
Source: S&P Capital IQ. Standard template. Financial Sources.